Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, August 2003, p. 2565-2571, Vol. 47, No. 8
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.8.2565-2571.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Plasmid-Mediated High-Level Resistance to Aminoglycosides in Enterobacteriaceae Due to 16S rRNA Methylation
Marc Galimand,1* Patrice Courvalin,1 and Thierry Lambert1,2
Unité des Agents Antibactériens, Institut Pasteur, 75724 Paris Cedex 15,1
Centre d'Etudes Pharmaceutiques, ChÂtenay-Malabry, France2
Received 5 February 2003/
Returned for modification 20 April 2003/
Accepted 17 May 2003

ABSTRACT
A self-transferable plasmid of ca. 80 kb, pIP1204, conferred
multiple-antibiotic resistance to
Klebsiella pneumoniae BM4536,
which was isolated from a urinary tract infection. Resistance
to ß-lactams was due to the
blaTEM1 and
blaCTX-M genes,
resistance to trimethroprim was due to the
dhfrXII gene, resistance
to sulfonamides was due to the
sul1 gene, resistance to streptomycin-spectinomycin
was due to the
ant3"9 gene, and resistance to nearly all remaining
aminoglycosides was due to the
aac3-II gene and a new gene designated
armA (aminoglycoside resistance methylase). The cloning of
armA into a plasmid in
Escherichia coli conferred to the new host
high-level resistance to 4,6-disubstituted deoxystreptamines
and fortimicin. The deduced sequence of ArmA displayed from
37 to 47% similarity to those of 16S rRNA m
7G methyltransferases
from various actinomycetes, which confer resistance to aminoglycoside-producing
strains. However, the low guanine-plus-cytosine content of
armA (30%) does not favor an actinomycete origin for the gene. It
therefore appears that posttranscriptional modification of 16S
rRNA can confer high-level broad-range resistance to aminoglycosides
in gram-negative human pathogens.

INTRODUCTION
Despite the development of new ß-lactams and fluoroquinolones,
aminoglycosides are still used for the treatment of severe infections
caused by gram-negative organisms. Bacterial resistance to these
drugs has been reported since their introduction into clinical
use (
37). There are three known mechanisms of resistance to
aminoglycosides in bacterial human pathogens: (i) decreased
intracellular accumulation of the antibiotic by alteration of
outer membrane permeability (
15), diminished inner membrane
transport (
39), or active efflux (
22,
25); (ii) modification
of the target by mutation in ribosomal proteins or 16S RNA;
and (iii) enzymatic modification of the drug (
37), which is
the most common. Microorganisms that produce aminoglycosides
have developed an additional pathway to avoid suicide. This
self-defense mechanism involves posttranscriptional methylation
of rRNA by use of
S-adenosylmethionine as a cofactor (
3).
Aminoglycosides act by causing translational errors and by inhibiting translocation (9). Their target sites include ribosomal domains in which the accuracy of the codon-anticodon is assessed (30, 46). In particular, they bind to a highly conserved motif of 16S RNA, which leads to alterations in the ribosome functions (24, 48). Substitution or methylation of bases involved in the binding between 16S rRNA and aminoglycosides can lead to a loss of affinity for the antibiotic and to the resistance of the host (7, 19, 29).
We have studied multiresistant Klebsiella pneumoniae BM4536 and found that a gene which encodes a putative 16S rRNA m7G methyltransferase is responsible for high-level resistance to a large number of aminoglycosides in this clinical isolate.

MATERIALS AND METHODS
Strains and growth conditions.
K. pneumoniae BM4536 was isolated from a urinary tract infection
at the Hôpital Saint-Michel in Paris in 2000.
Escherichia coli BM694 (
20), a spontaneous mutant of
E. coli C1a (
35) resistant
to nalidixic acid, and
E. coli INV

F' (Invitrogen, Paisley, United
Kingdom) were used as recipients for conjugation and cloning,
respectively. The strains were grown in brain heart infusion
broth and agar (Difco Laboratories, Detroit, Mich.) at 37°C.
Susceptibility testing.
Antibiotic susceptibility was determined by disk diffusion on Mueller-Hinton agar (Bio-Rad, Marnes-la-Coquette, France). The MICs of the antibiotics were determined by agar dilution with ca. 104 CFU per spot after 18 h of incubation at 37°C.
DNA preparation and transfer.
Isolation of total DNA and small- and large-scale preparation of plasmid DNA were performed as described previously (35). Restriction with endonucleases was done according to the recommendations of the supplier. Amplification of DNA was performed in a 2400 thermal cycler (Perkin-Elmer Cetus, Norwalk, Conn.) with Taq (Qbiogene, Inc., Carlsbad, Calif.) or Pfu (Stratagene, La Jolla, Calif.) DNA polymerase, as recommended by the manufacturers. PCR elongation times and temperatures were adjusted according to the expected size of the PCR product and to the nucleotide sequences of the primers, respectively. The primers used for detection and identification of various genes from pIP1204 are listed in Table 1. The aminoglycoside resistance gene was amplified with the specific oligodeoxynucleotides metF and metR (Table 1) by using plasmid pIP1204 DNA as a template. The amplification products were purified by using the QIAquick PCR purification kit (QIAGEN, Inc., Chatworth, Calif.).
Conjugation from
K. pneumoniae BM4536 to
E. coli BM694 was performed
with selection on 40 µg of nalidixic acid per ml and 20
µg of amikacin per ml. Transformation of
E. coli INV

F'
was done by the protocol provided by Invitrogen on brain heart
infusion agar containing 20 µg of amikacin per ml.
DNA sequence determination and analysis.
Both strands of the DNA were sequenced with synthetic oligodeoxynucleotides and a CEQ 2000 DNA analysis system automatic sequencer (Beckman Coulter, Fullerton, Calif.). The nucleotide and deduced amino acid sequences were analyzed with the GCG sequence analysis software package (version 10.1; Genetics Computer Group, Madison, Wis.). Searches of sequences were performed with the BLAST program, available the National Center for Biotechnology Information website (http://www.ncbi.nim.nih.gov/). Multiple-sequence alignment was performed with the ClustalX program, available at the Institut National de la Recherche Agronomique website (http://genome.jouy.inra.fr/); TreeView software; and the PROSITE database, available at ExPASy (http://www.expasy.org).
Enzymes and chemicals.
T4 DNA ligase was from Biolabs (Beverly, Mass.), and RNaseA (bovine pancreas) was from Calbiochem-Behring (La Jolla, Calif.). The following antibiotics were from the indicated providers: amikacin, ampicillin, and kanamycin B, Bristol-Myers Squibb (Princeton, N.J.); tobramycin, Eli Lilly & Co. (Indianapolis, Ind.); gentamicin, isepamicin, and netilmicin, Schering-Plough Research Institute (Kenilworth, N.J.); and apramycin, spectinomycin, and streptomycin, Sigma-Aldrich (Saint Quentin Fallavier, France).
Nucleotide sequence accession number.
The nucleotide sequence of the armA gene and its flanking regions has been deposited in the GenBank data library under accession number AY220558.

RESULTS
Antibiotic resistance of K. pneumoniae BM4536.
Clinical isolate
K. pneumoniae BM4536 was resistant to cefotaxime,
trimethoprim, and sulfonamides and had an unusual phenotype
of broad-spectrum high-level resistance to aminoglycosides,
including amikacin, dibekacin, 5-episisomicin, fortimicin, isepamicin,
gentamicin, kanamycin, netilmicin, 2'- and 6'-
N-ethylnetilmicin,
sisomicin, tobramycin, streptomycin, and spectinomycin (Table
2). Resistance to these drugs was transferable en bloc by conjugation
to
E. coli BM694. Analysis of the plasmid DNA content of one
of the transconjugants, BM4537, indicated the presence of plasmid
pIP1204, which was ca. 80 kb, as estimated by agarose gel electrophoresis
after digestion with
PstI or
EcoRI (data not shown).
Determination of the sequences of the PCR products obtained
with the oligonucleotides listed in Table
1 and pIP1204 DNA
as a template indicated that resistance to ß-lactams
was due to the presence of the
blaTEM-1 and
blaCTX-M3 genes
and also revealed the presence of IS
Ecp1, which is often located
upstream from the latter gene (
34). Resistance to streptomycin-spectinomycin
was due to the
ant3"9 gene, resistance to certain aminoglycosides
was due to
aac3-IIa, and resistance to trimethroprim was due
to a
dhfrXII gene. Resistance to sulfonamides was mediated by
sul1, and detection of the
intI1 structural gene suggested the
presence of a type I integron.
Characterization of aminoglycoside resistance.
Plasmid DNA from E. coli BM4537 and pUC18 DNA were digested with HindIII, mixed, ligated, and introduced by transformation into E. coli INV
F'. Transformants selected on medium containing amikacin were screened for their plasmid contents by agarose gel electrophoresis of crude bacterial lysates. The smallest plasmid, pAT780, contained a ca. 4-kb insert that was sequenced. The plasmid conferred to the new host high-level resistance to amikacin, 5-episisomicin, isepamicin, fortimicin, gentamicin, netilmicin, 2'- and 6'-N-ethylnetilmicin, sisomicin, and tobramycin but not to apramycin, lividomycin, neomycin B, paromomycin, or ribostamycin (Table 2 and data not shown).
Sequence analysis of the aminoglycoside resistance gene and the deduced protein.
Comparison of the sequence of the insert in pAT780 with sequences in the GenBank data library revealed identity to a portion of plasmid pCTX-M3 from Citrobacter freundii (positions 70,408 to 74,449; GenBank accession number AF550415). The insert contained four open reading frames (ORFs). The sequence of ORF1 (positions 1 to 579), truncated by the HindIII cloning, was found to be identical to that of the 3' end of ORF513, which specifies a putative recombinase in E. coli (100% identity over 192 amino acids; GenBank accession number AF174129). The sequence of ORF2 (positions 761 to 1652) was homologous to that of a putative transposase of Providencia rettgeri (76% identity over 245 amino acids; GenBank accession number L06418). The sequence of ORF3 (positions 1826 to 2751) did not share homology with any of the sequences in GenBank, but the deduced sequence was found to be similar to that of the 16S rRNA methyltransferase from Streptoalloteichus hindustanus (27% identity over 257 amino acids; GenBank accession number AF038408). The sequence of the last ORF, truncated by the HindIII cloning (positions 3440 to 4042), was homologous to that of the putative transposase of Tn1330 from Yersinia enterocolitica (40% identity over 192 amino acids; GenBank accession number AJ344215).
Within ORF3, a ribosome binding site, GTAGG (positions 1964 to 1968), was found 9 nucleotides upstream from an ATG initiation codon (position 1978), leading to a 771-bp putative coding sequence. Analysis of the upstream sequence indicated a putative promoter consisting of the -35 (TTGACG) (positions 1792 to 1797) and -10 (TACACT) motifs separated by 18 nucleotides (the underlined bases indicate identity with the -35 and -10 consensus promoter elements recognized by the E. coli
70 factor). The putative aminoglycoside resistance gene, named armA for aminoglycoside resistance methyltransferase, specifies a protein with a calculated mass of 28,811 Da. The overall guanine-plus-cytosine content of the armA gene (30%) was significantly lower than that of the sequence from the flanking DNA regions (ca. 50%).
The deduced protein, ArmA, showed homology with a closely related group of 16S rRNA methyltransferases, the Agr (aminoglycoside resistance) family (Table 3 and Fig. 1) (4). These include Grm from Micromonospora purpurea (41) and Micromonospora rosea (17), KgmB from Streptomyces tenebrarius (16), Kmr from Streptomyces kanamyceticus (10), NbrB from Streptoalloteichus hindustanus (accession number AAB95477), Sgm from Micromonospora zionensis (18), Kgm from Streptomyces lividans (40), FmrO from Micromonospora olivasterospora (28), and MagrA from Pseudomonas aeruginosa (accession number AB083212). The levels of identity of ArmA with these proteins were between 21 and 30%, and the levels of similarity were between 37 and 47% (Table 3).
Resistance conferred by the armA gene.
The sequence encoding the putative ArmA 16S rRNA methyltransferase
was amplified by PCR with primers metF and metR (Table
1); cloned
into pCR2, a PCR product cloning vector; and resequenced. The
771-bp
EcoRI fragment was ligated into the high-copy-number
vector pUC18 to generate pAT781 and into the low-copy-number
plasmid pACYC184 to generate pAT782. The recombinant plasmids
conferred to
E. coli INV

F' high-level resistance to the 4,6-disubstituted
deoxystreptamines and, in addition, to the structurally unrelated
compound fortimicin. Susceptibilities to the 4-5-disubstituted
deoxystreptamines lividomycin, neomycin B, paromomycin, and
ribostamycin were not affected, nor were susceptibilities to
apramycin, streptomycin, and spectinomycin (Table
2). Plasmids
pIP781 and pIP782 conferred a phenotype of very high-level resistance
to the host, indicating a lack of a gene dosage effect for this
mechanism. This observation accounts for the fact that plasmid
pIP1204, most likely present at a low copy number, is associated
with high-level resistance to aminoglycosides that are not substrates
for the 3-
N-aminoglycoside acetyltransferase type IIa.

DISCUSSION
Aminoglycosides are polycationic molecules, and their positive
charges interact with the negatively charged nucleic acids.
More specifically, they display high affinities with certain
domains of prokaryotic rRNA (
31,
32,
33,
44). The flexibility
of the aminoglycosides allows their adaptation to the shape
of the binding pocket in the internal loops of RNA helix cores
to make specific contacts (
12,
45,
47). The majority of these
antibiotics are composed of amino sugars linked to a 2-deoxystreptamine
ring (
19). The conserved elements among aminoglycosides are
rings I and II and, within ring II, the amino groups at positions
1 and 3. These elements are crucial for the binding to the decoding
site of 16S rRNA of prokaryotic ribosomes. The 2-deoxystreptamine
ring is substituted, most commonly, at positions 4 and 5, as
in the neomycin class, or at positions 4 and 6, as in the kanamycin
and gentamicin classes (
19).
A highly conserved sequence in the A site of 16S rRNA governs the interaction between the codon and the aminoacyl-tRNA anticodon (8, 27, 48). Most aminoglycosides bind to this region in a pocket created by asymmetry in the internal loop due to the A1408 · A1493 base pair and the single bulged adenine at position 1492 and interfere with several steps of translation, in particular, by inducing codon misreading (9, 36). The link between 16S rRNA and the aminoglycosides is crucial for antimicrobial activity, since mutations in the A site or modification of these antibiotics by bacterial enzymes affects this interaction, leading to resistance. The major difference in the binding sites of these antibiotics between prokaryotic and eukaryotic ribosomes is the nucleotide at position 1408 (E. coli numbering), which is an adenosine in prokaryotes and a guanosine in eukaryotes (31). Study of the interaction of aminoglycosides with small RNA molecules (14, 21, 30) and aptamers (42, 44) combined with the knowledge of the structure of the 30S ribosomal subunit (5) allowed identification of the bases involved in the binding. The nucleotides involved in the activities of the aminoglycosides are confined to a very limited number of bases mainly located in the A site. For example, critical positions for paramomycin binding to the A site include the C1407 · G1494 base pair, A1408, A1493, and U1495 (12). The 16S rRNA alterations which confer resistance to 4,6-linked aminoglycosides could be due to mutations (29) or RNA-modifying enzymes (3, 16, 38), with methylation being the simplest and most common RNA modification.
In prokaryotes, methylation of the bases is usual, whereas in eukaryotes, methylation of the ribose moiety (2'-O-methylation) is far more common. The majority of RNA methylation is carried out by S-adenosyl-L-methionine (AdoMet)-dependent methyltransferases (1, 2, 6). Methyltransferases constitute a large family of ubiquitous enzymes involved in various key biochemical reactions (23). Despite differences in their primary sequences, nine conserved blocks of amino acids have been recognized among these enzymes; and most DNA methyltransferases share a catalytic domain constituted of a ß sheet flanked by
helices, related to the nucleotide-binding Rossman fold (23). RNA methylation can have diverse effects on the binding of the aminoglycosides. The naturally occurring m5C1407 located within the aminoglycoside-binding domain of the A site does not adversely affect affinity for the drugs (45). Curiously, the absence of posttranscriptional modification at A1518 and at the adjacent A1519 in strains lacking a functional KsgA methyltransferase leads to kasugamycin resistance (43). By contrast, two methyltransferases with activities involving 16S rRNA that result in resistance to aminoglycosides have been identified. The first one, KamA, which corresponds to the conversion of A1408 to N-1 methyladenosine and which leads to kanamycin and apramycin resistance, has been reported in the istamycin producer Streptomyces tenjimariensis (28). The second, mediated by GmrA, converts G1405 N-7 to 7-methylguanosine and confers resistance to the gentamicin-producing species M. purpurea (3). GmrA belongs to the closely related family of methyltransferases designated Agr, which includes 10 members, all but 1 (MagrA from P. aeruginosa) of which originate in actinomycetes. It has been established for at least two members that modification converts G1405 within 16S rRNA to 7-methylguanosine (3), resulting in high-level resistance to certain aminoglycosides; G1405 is located in an extremity of the A site of the decoding region. Interestingly, although the Agr family of methyltransferases differs from other methyltransferases, structure predictions confirm the presence of a putative AdoMet-binding site, albeit at a location distinct from that in the other proteins (4).
The sequence of 257-amino-acid ArmA protein of K. pneumoniae BM4536 exhibited significant similarity with the sequences of the Agr family (Table 3; Fig. 1). The alternative motifs proposed by Bujnicki and Rychlewski (4) for Agr proteins, which are equivalent to the conserved 9-amino-acid blocks in the nucleic acid methyltransferases, were present in ArmA (Fig. 1). Two of the three amino acids predicted to form the AdoMet-binding site (Gly142 and Asp163) were conserved, and amino acids suspected to interact at the active site were identical or similar to those in the other members of the Agr family (Fig. 1). The resistance phenotype conferred by ArmA (Table 1) strongly suggests modification of G1405, since methylation of this base confers resistance to 4,6-linked 2-deoxystreptamine aminoglycosides but does not affect binding of 4,5-linked derivatives (3, 45).
The phylogenetic tree drawn from the primary sequences of the enzymes (Fig. 2) indicated that Sgm, Kgm, GrmA, and GrmB constitute a cluster and that Kgm and NbrB form a second group equally distant from the first cluster and from Kmr. The three remaining proteins, FmrO, MagrA, and ArmA, were similarly distant from each other and from the other Agr enzymes.
The base composition of
armA was significantly different from
that of the flanking DNA, suggesting acquisition of an exogenous
resistance determinant by plasmid pIP1204. However, its low
guanine-plus-cytosine content of 30%, very distinct from those
of
kgmB (71%) and
grmA (65%), does not favor a direct and recent
origin of the resistance gene in the actinomycetes. There are
few nonactinomycete aminoglycoside producers, such as gram-positive
bacilli (
26), and because of the absence of sequences homologous
to
armA in the data banks, the identity of the progenitor of
the gene remains open.
Posttranscriptional methylation of rRNA, previously confined to aminoglycoside producers, is a new mechanism of resistance to these drugs in human pathogens. This mechanism is particularly efficient since it modifies all 16S rRNA copies and thus leads to high-level resistance to all the aminoglycosides, except streptomycin, used in human therapy, even when the corresponding gene was present at a low copy number (Table 2). This is in contrast to rRNA gene mutations, which must occur in a minimum number of gene copies to confer clinical resistance (19, 29). The armA gene was borne by conjugative plasmid pIP1204, in which it is flanked by putative transposable elements and linked to blaCTX-M, which confers resistance to broad-spectrum cephalosporins by synthesis of an extended-spectrum ß-lactamase. All these elements favor dissemination of armA, and it is thus not surprising that we found the gene in various members of the family Enterobacteriaceae isolated from several European countries (data not shown).

ACKNOWLEDGMENTS
We thank L. Sañudo and S. Simon for technical assistance.

FOOTNOTES
* Corresponding author. Mailing address: Unité des Agents Antibactériens, Institut Pasteur, 25, rue du Docteur Roux, 75724 Paris Cedex 15, France. Phone: (33) (1) 45 68 83 18. Fax: (33) (1) 45 68 83 19. E-mail:
galimand{at}pasteur.fr.


REFERENCES
1 - Alexandrov, A., M. R. Martzen, and E. M. Phizicky. 2002. Two proteins that form a complex are required for 7-methylguanosine modification of yeast tRNA. RNA 8:1253-1266.[Abstract]
2 - Anantharamian, V., E. V. Koonin, and L. Aravind. 2002. SPOUT: a class of methyltransferases that includes spoU and trmD RNA methylase superfamilies, and novel superfamilies of predicted prokaryotic RNA methylases. J. Mol. Microbiol. Biotechnol. 4:71-75.[Medline]
3 - Beauclerk, A. A., and E. Cundliffe. 1987. Sites of action of two ribosomal RNA methylases responsible for resistance to aminoglycosides. J. Mol. Biol. 193:661-671.[CrossRef][Medline]
4 - Bujnicki, J. M., and L. Rychlewski. 2001. Sequence analysis and structure prediction of aminoglycoside-resistance 16S rRNA:m7G methyltransferases. Acta Microbiol. Pol. 50:7-17.[Medline]
5 - Carter, A. P., W. M. Clemons, D. E. Brodersen, R. J. Morgan-Warren, B. T. Wimberly, and V. Ramakrishnan. 2000. Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature 407:340-348.[CrossRef][Medline]
6 - Cheng, X., and R. J. Roberts. 2001. AdoMet-dependent methylation, DNA methyltransferases and base flipping. Nucleic Acids Res. 29:3784-3795.[Abstract/Free Full Text]
7 - Cundliffe, E. 1990. Recognition sites for antibiotics within rRNA, p. 479-490. In W. E. Hill, P. B. Moore, A. Dahlberg, D. Schlessinger, R. A. Garrett, and J. R. Warner (ed.), The ribosome: structure, function, and evolution. American Society for Microbiology, Washington, D.C.
8 - Cunningham, P. R., K. Nurse, A. Bakin, C. J. Weitzmann, M. Pflumm, and J. Ofengand. 1992. Interaction between the two conserved single-stranded regions at the decoding site of small subunit ribosomal RNA is essential for ribosome function. Biochemistry 31:12012-12022.[CrossRef][Medline]
9 - Davies, J., and B. D. Davis. 1968. Misreading of ribonucleic acid code words induced by aminoglycoside antibiotics. J. Biol. Chem. 243:3312-3316.[Abstract/Free Full Text]
10 - Demydchuk, J., Z. Oliynyk, and V. Fedorenko. 1998. Analysis of a kanamycin resistance gene (kmr) from Streptomyces kanamyceticus and a mutant with increased aminoglycoside resistance. J. Basic Microbiol. 38:231-239.[CrossRef][Medline]
11 - Felsentein, J. 1985. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39:783-791.[CrossRef]
12 - Fourmy, D., M. I. Recht, S. C. Blanchard, and J. D. Puglisi. 1996. Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic. Science 274:1367-1371.[Abstract/Free Full Text]
13 - Gniadkowski, M., I. Schneider, R. Jungwirth, B. Mikiewicz, and A. Bauernfeind. 1998. Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing ß-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob. Agents Chemother. 42:827-832.[Abstract/Free Full Text]
14 - Hamasaki, K., J. Killian, J. Cho, and R. R. Rando. 1998. Minimal RNA constructs that specifically bind aminoglycoside antibiotics with high affinities. Biochemistry 37:656-663.[CrossRef][Medline]
15 - Hancock, R. E. W. 1981. Aminoglycoside uptake and mode of actionwith special reference to streptomycin and gentamicin. J. Antimicrob. Chemother. 8:249-276.
16 - Holmes, D. J., and E. Cundliffe. 1991. Analysis of a ribosomal RNA methylase gene from Streptomyces tenebrarius which confers resistance to gentamicin. Mol. Gen. Genet. 229:229-237.[CrossRef][Medline]
17 - Kelemen, G. H., E. Cundliffe, and I. Financsek. 1991. Cloning and characterization of gentamicin-resistance genes from Micromonospora purpurea and Micromonospora rosea. Gene 98:53-60.[CrossRef][Medline]
18 - Kojic, M., L. Topisirovic, and B. Vasiljevic. 1992. Cloning and characterization of an aminoglycoside resistance determinant from Micromonospora zionensis. J. Bacteriol. 174:7868-7872.[Abstract/Free Full Text]
19 - Kotra, L. P., J. Haddad, and S. Mobashery. 2000. Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance. Antimicrob. Agents Chemother. 44:3249-3256.[Free Full Text]
20 - Labigne-Roussel, A., G. Gerbaud, and P. Courvalin. 1981. Translocation of sequences encoding antibiotic resistance from the chromosome to a receptor plasmid in Salmonella ordonez. Mol. Gen. Genet. 182:390-408.[CrossRef][Medline]
21 - Lynch, S. R., R. L. Gonzalez, and J. D. Puglisi. 2003. Comparison of X-ray crystal structure of the 30S subunit-antibiotic complex with NMR structure of decoding site oligonucleotide-paramomycin complex. Structure 11:43-53.[Medline]
22 - Magnet, S., P. Courvalin, and T. Lambert. 2001. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother. 45:3375-3380.[Abstract/Free Full Text]
23 - Malone, T., R. M. Blumenthal, and X. Cheng. 1995. Structure-guided analysis reveals nine sequence motifs conserved among DNA amino-methyl-transferases, and suggests a catalytic mechanism for these enzymes. J. Mol. Biol. 253:618-632.[CrossRef][Medline]
24 - Moazed, D., and H. F. Noller. 1987. Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature 327:389-394.[CrossRef][Medline]
25 - Moore, R. A., D. Deshazer, S. Reckseidler, A. Weissman, and D. E. Woods. 1999. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob. Agents Chemother. 43:465-470.[Abstract/Free Full Text]
26 - Nara, T., I. Kawamoto, R. Okachi, and T. Oka. 1977. Source of antibiotics other than Streptomyces. J. Antibiot. 30:S174-S189.
27 - Ogle, J. M., E. Brodersen, W. M. Clemons, M. J. Tarry, A. P. Carter, and V. Ramakrishnan. 2001. Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science 292:897-902.[Abstract/Free Full Text]
28 - Ohta, T., and M. Hasegawa. 1993. Analysis of the self-defense gene (fmrO) of a fortimicin A (astromicin) producer, Micromonospora olivasterospora: comparison with other aminoglycoside-resistance-encoding genes. Gene 127:63-69.[CrossRef][Medline]
29 - Prammananan, T., P. Sander, B. A. Brown, K. Frischkorn, G. O. Onyi, Y. Zhang, E. Bottger, and R. J. Wallace, Jr. 1998. A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. J. Infect. Dis. 177:1573-1581.[Medline]
30 - Purohit, P., and S. Stern. 1994. Interactions of a small RNA with antibiotic and RNA ligands of the 30S subunit. Nature 370:659-662.[CrossRef][Medline]
31 - Recht, M. I., S. Douthwaite, K. D. Dahlquist, and J. D. Puglisi. 1999. Effect of mutations in the A site of 16S rRNA on aminoglycoside antibiotic-ribosome interaction. J. Mol. Biol. 286:33-43.[CrossRef][Medline]
32 - Recht, M. I., S. Douthwaite, and J. D. Puglisi. 1999. Basis for prokaryotic specificity of action of aminoglycoside antibiotics. EMBO J. 18:3133-3138.[CrossRef][Medline]
33 - Recht, M. I., D. Fourmy, S. C. Blanchard, K. D. Dahlquist, and J. D. Puglisi. 1996. RNA sequence determinants for aminoglycoside binding to an A-site rRNA model oligonucleotide. J. Mol. Biol. 262:421-436.[CrossRef][Medline]
34 - Saladin, M., V. T. B. Cao, T. Lambert, J.-L. Donay, J.-L. Hermann, Z. Ould-Hocine, C. Verdet, F. Delisle, A. Philipon, and G. Arlet. 2002. Diversity of CTX-M ß-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol. Lett. 209:161-168.[Medline]
35 - Sambrook, J., and D. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
36 - Schroeder, R., C. Waldsich, and H. Wank. 2000. Modulation of RNA function by aminoglycoside antibiotics. EMBO J. 19:1-9.[CrossRef][Medline]
37 - Shaw, K. J., P. N. Rather, R. S. Hare, and G. H. Miller. 1993. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol. Rev. 57:138-163.[Abstract/Free Full Text]
38 - Skeggs, P. A., D. J. Holmes, and E. Cundliffe. 1987. Cloning of aminoglycoside-resistance determinants from Streptomyces tenebrarius and comparison with related genes from other actinomycetes. J. Gen. Microbiol. 133:915-923.[Abstract/Free Full Text]
39 - Taber, H. W., J. P. Mueller, P. F. Miller, and A. Arrow. 1987. Bacterial uptake of aminoglycoside antibiotics. Microbiol. Rev. 51:439-457.[Free Full Text]
40 - Takano, E., J. White, C. J. Thompson, and M. J. Bibb. 1995. Construction of thiostrepton-inducible high-copy-number expression vectors for use in Streptomyces spp. Gene 166:133-137.[CrossRef][Medline]
41 - Thompson, C. J., P. A. Skeggs, and E. Cundliffe. 1985. Methylation of 16S ribosomal RNA and resistance to the aminoglycoside antibiotics gentamicin and kanamycin determined by DNA from the gentamicin-producer, Micromonospora purpurea. Mol. Gen. Genet. 201:168-173.[CrossRef][Medline]
42 - Tok, J. B. H., J. Cho, and R. R. Rando. 2000. RNA aptamers that specifically bind to a 16S ribosomal RNA decoding region construct. Nucleic Acids Res. 15:2902-2910.
43 - van Buul, C. P., and P. H. Knippenberg. 1985. Nucleotide sequence of the ksgA gene of Escherichia coli: comparison of methyltransferases effecting dimethylation of adenosine in ribosomal RNA. Gene 38:65-72.[CrossRef][Medline]
44 - Wallace, S. T., and R. Schroeder. 1998. In vitro selection and characterization of streptomycin-binding RNAs: recognition discrimination between antibiotics. RNA 4:112-123.[Abstract]
45 - Wong, C.-H., M. Hendrix, E. S. Priestley, and W. A. Greenberg. 1998. Specificity of aminoglycoside antibiotics for the A-site of the decoding region of ribosomal RNA. Chem. Biol. 5:397-406.[CrossRef][Medline]
46 - Woodcock, J., D. Moazed, M. Cannon, J. Davies, and H. F. Noller. 1991. Interaction of antibiotics with A- and P-site-specific bases in 16S ribosomal RNA. EMBO J. 10:3099-3103.[Medline]
47 - Yoshizawa, S., D. Fourmy, and J. D. Puglisi. 1998. Structural origins of gentamicin antibiotic action. EMBO J. 22:6437-6448.[CrossRef]
48 - Yoshizawa, S., D. Fourmy, and J. D. Puglisi. 1999. Recognition of the codon-anticodon helix by ribosomal RNA. Science 285:1722-1725.[Abstract/Free Full Text]
Antimicrobial Agents and Chemotherapy, August 2003, p. 2565-2571, Vol. 47, No. 8
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.8.2565-2571.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Lister, P. D., Wolter, D. J., Hanson, N. D.
(2009). Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms. Clin. Microbiol. Rev.
22: 582-610
[Abstract]
[Full Text]
-
Naas, T., Bentchouala, C., Lima, S., Lezzar, A., Smati, F., Scheftel, J.-M., Nordmann, P.
(2009). Plasmid-mediated 16S rRNA methylases among extended-spectrum-{beta}-lactamase-producing Salmonella enterica Senftenberg isolates from Algeria. J Antimicrob Chemother
64: 866-868
[Full Text]
-
Savic, M., Lovric, J., Tomic, T. I., Vasiljevic, B., Conn, G. L.
(2009). Determination of the target nucleosides for members of two families of 16S rRNA methyltransferases that confer resistance to partially overlapping groups of aminoglycoside antibiotics. Nucleic Acids Res
37: 5420-5431
[Abstract]
[Full Text]
-
Cubrilo, S., Babic, F., Douthwaite, S., Maravic Vlahovicek, G.
(2009). The aminoglycoside resistance methyltransferase Sgm impedes RsmF methylation at an adjacent rRNA nucleotide in the ribosomal A site. RNA
15: 1492-1497
[Abstract]
[Full Text]
-
Arpin, C., Quentin, C., Grobost, F., Cambau, E., Robert, J., Dubois, V., Coulange, L., Andre, C., on behalf of the Scientific Committee of ONERBA,
(2009). Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting. J Antimicrob Chemother
63: 1205-1214
[Abstract]
[Full Text]
-
Kitao, T., Miyoshi-Akiyama, T., Kirikae, T.
(2009). AAC(6')-Iaf, a Novel Aminoglycoside 6'-N-Acetyltransferase from Multidrug-Resistant Pseudomonas aeruginosa Clinical Isolates. Antimicrob. Agents Chemother.
53: 2327-2334
[Abstract]
[Full Text]
-
Ma, L., Lin, C.-J., Chen, J.-H., Fung, C.-P., Chang, F.-Y., Lai, Y.-K., Lin, J.-C., Siu, L. K., and the Taiwan Surveillance of Antimicrobial Resis,
(2009). Widespread Dissemination of Aminoglycoside Resistance Genes armA and rmtB in Klebsiella pneumoniae Isolates in Taiwan Producing CTX-M-Type Extended-Spectrum {beta}-Lactamases. Antimicrob. Agents Chemother.
53: 104-111
[Abstract]
[Full Text]
-
Wu, Q., Zhang, Y., Han, L., Sun, J., Ni, Y.
(2009). Plasmid-Mediated 16S rRNA Methylases in Aminoglycoside-Resistant Enterobacteriaceae Isolates in Shanghai, China. Antimicrob. Agents Chemother.
53: 271-272
[Abstract]
[Full Text]
-
Bercot, B., Poirel, L., Nordmann, P.
(2008). Plasmid-Mediated 16S rRNA Methylases among Extended-Spectrum {beta}-Lactamase-Producing Enterobacteriaceae Isolates. Antimicrob. Agents Chemother.
52: 4526-4527
[Full Text]
-
Adams-Haduch, J. M., Paterson, D. L., Sidjabat, H. E., Pasculle, A. W., Potoski, B. A., Muto, C. A., Harrison, L. H., Doi, Y.
(2008). Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in Pennsylvania. Antimicrob. Agents Chemother.
52: 3837-3843
[Abstract]
[Full Text]
-
Zhang, Y., Zhou, H., Shen, X.-q., Shen, P., Yu, Y.-s., Li, L.-j.
(2008). Plasmid-borne armA methylase gene, together with blaCTX-M-15 and blaTEM-1, in a Klebsiella oxytoca isolate from China. J Med Microbiol
57: 1273-1276
[Abstract]
[Full Text]
-
Doi, Y., Wachino, J.-i., Arakawa, Y.
(2008). Nomenclature of Plasmid-Mediated 16S rRNA Methylases Responsible for Panaminoglycoside Resistance. Antimicrob. Agents Chemother.
52: 2287-2288
[Full Text]
-
Fritsche, T. R., Castanheira, M., Miller, G. H., Jones, R. N., Armstrong, E. S.
(2008). Detection of Methyltransferases Conferring High-Level Resistance to Aminoglycosides in Enterobacteriaceae from Europe, North America, and Latin America. Antimicrob. Agents Chemother.
52: 1843-1845
[Abstract]
[Full Text]
-
Zong, Z., Partridge, S. R., Iredell, J. R.
(2008). RmtC 16S rRNA Methyltransferase in Australia. Antimicrob. Agents Chemother.
52: 794-795
[Full Text]
-
Kang, H. Y., Kim, K. Y., Kim, J., Lee, J. C., Lee, Y. C., Cho, D. T., Seol, S. Y.
(2008). Distribution of Conjugative-Plasmid-Mediated 16S rRNA Methylase Genes among Amikacin-Resistant Enterobacteriaceae Isolates Collected in 1995 to 1998 and 2001 to 2006 at a University Hospital in South Korea and Identification of Conjugative Plasmids Mediating Dissemination of 16S rRNA Methylase. J. Clin. Microbiol.
46: 700-706
[Abstract]
[Full Text]
-
Wachino, J.-i., Shibayama, K., Kurokawa, H., Kimura, K., Yamane, K., Suzuki, S., Shibata, N., Ike, Y., Arakawa, Y.
(2007). Novel Plasmid-Mediated 16S rRNA m1A1408 Methyltransferase, NpmA, Found in a Clinically Isolated Escherichia coli Strain Resistant to Structurally Diverse Aminoglycosides. Antimicrob. Agents Chemother.
51: 4401-4409
[Abstract]
[Full Text]
-
Yu, Y.-s., Zhou, H., Yang, Q., Chen, Y.-g., Li, L.-j.
(2007). Widespread occurrence of aminoglycoside resistance due to ArmA methylase in imipenem-resistant Acinetobacter baumannii isolates in China. J Antimicrob Chemother
60: 454-455
[Full Text]
-
Perichon, B., Courvalin, P., Galimand, M.
(2007). Transferable Resistance to Aminoglycosides by Methylation of G1405 in 16S rRNA and to Hydrophilic Fluoroquinolones by QepA-Mediated Efflux in Escherichia coli. Antimicrob. Agents Chemother.
51: 2464-2469
[Abstract]
[Full Text]
-
Chen, L., Chen, Z.-L., Liu, J.-H., Zeng, Z.-L., Ma, J.-Y., Jiang, H.-X.
(2007). Emergence of RmtB methylase-producing Escherichia coli and Enterobacter cloacae isolates from pigs in China. J Antimicrob Chemother
59: 880-885
[Abstract]
[Full Text]
-
Doi, Y., de Oliveira Garcia, D., Adams, J., Paterson, D. L.
(2007). Coproduction of Novel 16S rRNA Methylase RmtD and Metallo-{beta}-Lactamase SPM-1 in a Panresistant Pseudomonas aeruginosa Isolate from Brazil. Antimicrob. Agents Chemother.
51: 852-856
[Abstract]
[Full Text]
-
Bogaerts, P., Galimand, M., Bauraing, C., Deplano, A., Vanhoof, R., De Mendonca, R., Rodriguez-Villalobos, H., Struelens, M., Glupczynski, Y.
(2007). Emergence of ArmA and RmtB aminoglycoside resistance 16S rRNA methylases in Belgium. J Antimicrob Chemother
59: 459-464
[Abstract]
[Full Text]
-
Aslangul, E., Massias, L., Meulemans, A., Chau, F., Andremont, A., Courvalin, P., Fantin, B., Ruimy, R.
(2006). Acquired Gentamicin Resistance by Permeability Impairment in Enterococcus faecalis. Antimicrob. Agents Chemother.
50: 3615-3621
[Abstract]
[Full Text]
-
Soge, O. O., Adeniyi, B. A., Roberts, M. C.
(2006). New antibiotic resistance genes associated with CTX-M plasmids from uropathogenic Nigerian Klebsiella pneumoniae. J Antimicrob Chemother
58: 1048-1053
[Abstract]
[Full Text]
-
Park, Y.-J., Lee, S., Yu, J. K., Woo, G.-J., Lee, K., Arakawa, Y.
(2006). Co-production of 16S rRNA methylases and extended-spectrum {beta}-lactamases in AmpC-producing Enterobacter cloacae, Citrobacter freundii and Serratia marcescens in Korea. J Antimicrob Chemother
58: 907-908
[Full Text]
-
Wachino, J.-i., Yamane, K., Kimura, K., Shibata, N., Suzuki, S., Ike, Y., Arakawa, Y.
(2006). Mode of Transposition and Expression of 16S rRNA Methyltransferase Gene rmtC Accompanied by ISEcp1.. Antimicrob. Agents Chemother.
50: 3212-3215
[Abstract]
[Full Text]
-
Jensen, V. F., Jakobsen, L., Emborg, H.-D., Seyfarth, A. M., Hammerum, A. M.
(2006). Correlation between apramycin and gentamicin use in pigs and an increasing reservoir of gentamicin-resistant Escherichia coli. J Antimicrob Chemother
58: 101-107
[Abstract]
[Full Text]
-
Toleman, M. A., Bennett, P. M., Walsh, T. R.
(2006). ISCR Elements: Novel Gene-Capturing Systems of the 21st Century?. Microbiol. Mol. Biol. Rev.
70: 296-316
[Abstract]
[Full Text]
-
Wachino, J.-i., Yamane, K., Shibayama, K., Kurokawa, H., Shibata, N., Suzuki, S., Doi, Y., Kimura, K., Ike, Y., Arakawa, Y.
(2006). Novel Plasmid-Mediated 16S rRNA Methylase, RmtC, Found in a Proteus mirabilis Isolate Demonstrating Extraordinary High-Level Resistance against Various Aminoglycosides. Antimicrob. Agents Chemother.
50: 178-184
[Abstract]
[Full Text]
-
Diaz, M. A., Cooper, R. K., Cloeckaert, A., Siebeling, R. J.
(2006). Plasmid-Mediated High-Level Gentamicin Resistance among Enteric Bacteria Isolated from Pet Turtles in Louisiana. Appl. Environ. Microbiol.
72: 306-312
[Abstract]
[Full Text]
-
Gonzalez-Zorn, B., Catalan, A., Escudero, J. A., Dominguez, L., Teshager, T., Porrero, C., Moreno, M. A.
(2005). Genetic basis for dissemination of armA. J Antimicrob Chemother
56: 583-585
[Abstract]
[Full Text]
-
Galimand, M., Sabtcheva, S., Courvalin, P., Lambert, T.
(2005). Worldwide Disseminated armA Aminoglycoside Resistance Methylase Gene Is Borne by Composite Transposon Tn1548. Antimicrob. Agents Chemother.
49: 2949-2953
[Abstract]
[Full Text]
-
Poole, K.
(2005). Aminoglycoside Resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
49: 479-487
[Full Text]
-
Yan, J.-J., Wu, J.-J., Ko, W.-C., Tsai, S.-H., Chuang, C.-L., Wu, H.-M., Lu, Y.-J., Li, J.-D.
(2004). Plasmid-mediated 16S rRNA methylases conferring high-level aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae isolates from two Taiwanese hospitals. J Antimicrob Chemother
54: 1007-1012
[Abstract]
[Full Text]
-
Yamane, K., Doi, Y., Yokoyama, K., Yagi, T., Kurokawa, H., Shibata, N., Shibayama, K., Kato, H., Arakawa, Y.
(2004). Genetic Environments of the rmtA Gene in Pseudomonas aeruginosa Clinical Isolates. Antimicrob. Agents Chemother.
48: 2069-2074
[Abstract]
[Full Text]
-
Doi, Y., Yokoyama, K., Yamane, K., Wachino, J.-i., Shibata, N., Yagi, T., Shibayama, K., Kato, H., Arakawa, Y.
(2004). Plasmid-Mediated 16S rRNA Methylase in Serratia marcescens Conferring High-Level Resistance to Aminoglycosides. Antimicrob. Agents Chemother.
48: 491-496
[Abstract]
[Full Text]